VJHemOnc is committed to improving our service to you

ASCO 2019 | Lymphoma: pre-treatment PET scans

VJHemOnc is committed to improving our service to you

Paolo Strati

Paolo Strati, MD, of the University of Texas MD Anderson Cancer Center, Houston, TX, highlights the key findings from a trial looking at pre-treatment PET scans of 346 patients with advanced stage fully grown lymphoma; observing that generally those with high SUVmax had a shorter overall survival rate, independent of the type of treatment used. Speaking from the American Society of Clinical Oncology (ASCO) 2019 Annual Meeting in Chicago, IL, Dr Strati demonstrates the need to determine the prognostic value of the pre-treatment PET scans and SUVmax measurement.

Share this video  

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter